- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.
Sanofi India reported a strong Q2, primarily driven by its diabetes unit, which saw over 14% growth and 17% for the half-year. Total income for the quarter rose 7%, with sales up 6%. Profit Before Tax (PBT) increased 19% to INR 112 Cr from INR 94 Cr, supported by a...